Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Statistics, School of Public Health, Southeast University, No. 87 Dingjiaqiao Road, Gulou District, Nanjing, Jiangsu, China.
National Research Institute for Family Planning, Beijing, China.
BMC Pregnancy Childbirth. 2024 Apr 3;24(1):233. doi: 10.1186/s12884-024-06418-x.
The association of genital Mollicutes infection transition with adverse pregnancy outcomes was insignificant among general pregnant women, but there remains a paucity of evidence linking this relationship in gestational diabetes mellitus (GDM) women. The aim was to investigate the association between genital Mollicutes infection and transition and adverse pregnancy outcomes in GDM women, and to explore whether this association still exist when Mollicutes load varied.
We involved pregnant women who attended antenatal care in Chongqing, China. After inclusion and exclusion criteria, we conducted a single-center cohort study of 432 GDM women with pregnancy outcomes from January 1, 2018 to December 31, 2021. The main outcome was adverse pregnancy outcomes, including premature rupture of membrane (PROM), fetal distress, macrosomia and others. The exposure was Mollicutes infection, including Ureaplasma urealyticum (Uu) and Mycoplasma hominis (Mh) collected in both the second and the third trimesters, and testing with polymerase chain reaction method. The logistic regression models were used to estimate the relationship between Mollicutes infection and adverse pregnancy outcomes.
Among 432 GDM women, 241 (55.79%) were infected with genital Mollicutes in either the second or third trimester of pregnancy. At the end of the pregnancy follow-up, 158 (36.57%) participants had adverse pregnancy outcomes, in which PROM, fetal distress and macrosomia were the most commonly observed adverse outcomes. Compared with the uninfected group, the Mollicutes (+/-) group showed no statistical significant increase in PROM (OR = 1.05, 95% CI:0.51 ∼ 2.08) and fetal distress (OR = 1.21, 95% CI: 0.31 ∼ 3.91). Among the 77 participants who were both Uu positive in the second and third trimesters, 38 participants presented a declined Uu load and 39 presented an increased Uu load. The Uu increased group had a 2.95 odds ratio (95% CI: 1.10~8.44) for adverse pregnancy outcomes.
Mollicutes infection and transition during trimesters were not statistically associated with adverse pregnancy outcomes in GDM women. However, among those consistent infections, women with increasing Uu loads showed increased risks of adverse pregnancy outcomes. For GDM women with certain Mollicutes infection and colonization status, quantitative screening for vaginal infection at different weeks of pregnancy was recommended to provide personalized fertility treatment.
一般孕妇的生殖道摩氏菌感染与不良妊娠结局之间的关联并不显著,但关于妊娠期糖尿病(GDM)妇女中这种关系的证据仍然很少。目的是探讨 GDM 妇女生殖道摩氏菌感染与过渡及不良妊娠结局之间的关系,并探讨在摩氏菌负荷变化时这种关系是否仍然存在。
我们纳入了在中国重庆接受产前保健的孕妇。经过纳入和排除标准后,我们进行了一项单中心队列研究,纳入了 2018 年 1 月 1 日至 2021 年 12 月 31 日期间妊娠结局的 432 名 GDM 妇女。主要结局是不良妊娠结局,包括胎膜早破(PROM)、胎儿窘迫、巨大儿等。暴露是在第二和第三个三个月采集的生殖道摩氏菌感染,包括解脲脲原体(Uu)和人型支原体(Mh),并采用聚合酶链反应方法进行检测。使用逻辑回归模型估计摩氏菌感染与不良妊娠结局之间的关系。
在 432 名 GDM 妇女中,241 名(55.79%)在妊娠的第二个或第三个三个月感染了生殖道摩氏菌。在妊娠随访结束时,158 名(36.57%)参与者出现了不良妊娠结局,其中胎膜早破、胎儿窘迫和巨大儿是最常见的不良结局。与未感染者相比,摩氏菌(+/-)组的胎膜早破(OR=1.05,95%CI:0.51∼2.08)和胎儿窘迫(OR=1.21,95%CI:0.31∼3.91)发生率无统计学显著增加。在 77 名在第二和第三个三个月均为 Uu 阳性的参与者中,38 名参与者的 Uu 负荷下降,39 名参与者的 Uu 负荷增加。Uu 增加组不良妊娠结局的比值比(OR)为 2.95(95%CI:1.10~8.44)。
在 GDM 妇女中,妊娠期摩氏菌感染和过渡与不良妊娠结局之间无统计学关联。然而,在那些持续感染的妇女中,Uu 负荷增加的妇女发生不良妊娠结局的风险增加。对于具有特定摩氏菌感染和定植状态的 GDM 妇女,建议在不同妊娠周进行阴道感染定量筛查,以提供个性化生育治疗。